-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Inhibrx Biosciences, Inc. quarterly Depreciation, Depletion and Amortization history and growth rate from Q2 2023 to Q3 2024.
- Inhibrx Biosciences, Inc. Depreciation, Depletion and Amortization for the quarter ending September 30, 2024 was $760K, a 150% increase year-over-year.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)